Browse all clinical trials

Sponsor Updatedsort icon
Phase I A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Bristol-Myers Squibb 2009-05-20
Phase II Study to Evaluate the Effect of Cetuximab on Corrected QT Interval Changes in Patients With Advanced Malignancies From Solid Tumors Bristol-Myers Squibb 2009-05-20
Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690) Schering-Plough 2009-05-20
Phase III Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage The Medicines Company 2009-05-20
Phase III Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients Bristol-Myers Squibb 2009-05-20
Phase III An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets Bristol-Myers Squibb 2009-05-20
Phase II A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer Bristol-Myers Squibb 2009-05-20
The Effect of Ethanol on Overnight Glucose Regulation in Type 2 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Phase III Add-on to Thiazolidinedione (TZD) Failures Bristol-Myers Squibb 2009-05-20
Phase III Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Hip Replacement Surgery Bristol-Myers Squibb 2009-05-20
Phase IV A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843) Schering-Plough 2009-05-20
Phase I Effects of N-Acetylcysteine on Muscle Fatigue in Hemodialysis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Phase I Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma National Cancer Institute (NCI) 2009-05-20
Phase II Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb 2009-05-20
Phase I Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer Dartmouth-Hitchcock Medical Center 2009-05-20
Phase II Oxaliplatin, Capecitabine, Cetuximab, and Radiation Therapy Followed By Surgery in Treating Patients With Stage II or Stage III Rectal Cancer National Cancer Institute (NCI) 2009-05-20
Phase I A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin Bristol-Myers Squibb 2009-05-20
Phase III A Study of Tanespimycin (KOS-953) in Patients With Relapsed-Refractory Multiple Myeloma Bristol-Myers Squibb 2009-05-20
Phase II Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-Menopausal Women AstraZeneca 2009-05-20
Phase II Phase II Study of Dasatinib (BMS-354825) for Androgen-Deprived Progressive Prostate Cancer Bristol-Myers Squibb 2009-05-20
Phase III Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma National Cancer Institute (NCI) 2009-05-20
Phase III Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness Bristol-Myers Squibb 2009-05-20
Phase III Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors National Cancer Institute (NCI) 2009-05-20
Phase I A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer Bristol-Myers Squibb 2009-05-20